Biosimilar Interchangeability Switching Studies May Use Foreign Comparators US FDA Says

Biosimilar Interchangeability Switching Studies May Use Foreign Comparators, US FDA Says

17:36 EDT 12 May 2019 | SCRIP

But scientific bridging required for non-US reference products might be more extensive than in other contexts, agency cautions; easing of...

More From BioPortfolio on "Biosimilar Interchangeability Switching Studies May Use Foreign Comparators, US FDA Says"